Despite a slump in annual additions, the global bioenergy market is set to show steady growth, rising from 106.2 GW of installed capacity in 2015 to 165.2 GW by 2025, at a compound annual growth rate of 4.4%, according to research and consulting firm GlobalData. The company’s latest report states that bioenergy is a niche market in the renewable energy industry, and is likely to grow at a significant rate in the future. Although bioenergy is not a new concept, recent advancements have improved both performance and reliability. The increases in global energy demand and climate change concerns are the primary growth drivers for the biopower industry.
The major driver for the successful deployment of large-scale bioenergy plants is government support in terms of renewable energy mandates and financial incentives, such as subsidies and production tax credits. Additionally, environmental regulations for emissions reductions discourage the use of fossil fuels for power generation, meaning alternatives such as bioenergy or other renewable energy sources are required.
The top 10 active bioenergy plants are mainly wood or agricultural by-product dependent, and Europe and the US dominate the market geographically. The UK-based Drax Biomass Power Plant is the leading active bioenergy plant, with 630 MW of total capacity. Other large plants include Jaboticabal Biomass Power Plant, which has a capacity of 302 MW and is owned by Brazilian company Destiliaria Santa Clara Ltd, and Aros G4 CHP, which is owned by Malarenergi AB and has a capacity of 243 MW.